Pharmaceutical Industry

Drug Development Drug Pricing Market Trends Drug Manufacturers Market Competition Drug Manufacturing Novo Nordisk Vaccine Development Market Dynamics Companies Pharmaceutical Companies Vaccine Manufacturers Stock Market Drug Market Generic Drugs Pricing Strategies Manufacturing Eli Lilly Vaccine Production Pfizer Corporate Responsibility Drug Companies Market Analysis Corporate Governance Drug Approval Research and Development Compounding Pharmacies Vaccine Market Weight Loss Drugs Clinical Trials Drug Distribution Big Pharma Investment Drug Production Weight-Loss Drugs Biotechnology Companies Competition Regulations Mergers and Acquisitions Partnerships Company Performance AstraZeneca Health Products Market Impact Purdue Pharma Lobbying Moderna Drug Approval Process Pharmacy Benefit Managers Drug Sales Drug Marketing Vaccine Manufacturing Market Strategies Drug Approvals Product Safety FDA Regulations Company Acquisitions Acquisitions Corporate Ethics Regulatory Compliance Drug Safety Market Access Sales Regulatory Affairs Supply Chain Management Product Launch Online Pharmacies Biotechnology Corporate Acquisitions Marketing Strategies Market Practices Opioid Crisis Market Performance Pharmacy Chains Biotech Companies Pharmacy Operations GSK Drug Prices Company Strategies Amylyx Pharmaceuticals Drugmakers Market Regulation Telehealth Drug Pricing Strategies Johnson & Johnson Product Development Market Demand Product Recalls Product Recall Marketing Practices FDA Approval Manufacturers Drug Supply Chain Weight Loss Drug Market Corporate Practices Product Liability Government Regulation Market Reactions Corporate Decisions Cost Management

Rep. Shri Thanedar Faces Scrutiny Over Animal Abandonment While Pursuing Trump Impeachment

The Michigan congressman defends his impeachment articles against Donald Trump as opponents highlight a 2010 lab scandal involving over 170 abandoned animals.

Sanofi Finalizes €10 Billion Sale of Opella to U.S. Fund CD&R

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

Argentine Court Suspends Milei's Decree on Over-the-Counter Drug Sales

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Pakistan Scrambles to Secure Drug Supplies After Trade Suspension with India

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

California Expands Access to Affordable Naloxone for Residents

Trump Administration Weighs Pilot to Tie U.S. Drug Prices to Global Benchmarks

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Germany's Electronic Patient Record Prepares for Nationwide Rollout

€1 Million in Cancer Medications Stolen from AP-HP Supplier in Nanterre

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

Trump Signs Executive Order Targeting Lower Drug Prices and Medicare Reforms

WHO Finalizes Historic Pandemic Preparedness Treaty

German Court Approves Pharmacist's Production of Unapproved Cancer Drug

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Verve-102 Gene-Editing Therapy Shows Promising LDL Cholesterol Reduction in Early Trial

WHO Members Reach Historic Agreement in Principle on Pandemic Treaty

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Eli Lilly Sues Strive and Empower Over Unapproved Tirzepatide Products

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

FDA Approves VYKAT XR, First Therapy for Hyperphagia in Prader-Willi Syndrome

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Australia Stands Firm on PBS as US Pharma Pushes for Tariffs

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Sanofi Employees Protest Planned Sale of Amilly Factory

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

EU Pushes to Boost Domestic Drug Production Amid Supply Chain Concerns

EU Unveils Critical Medicines Act to Address Drug Shortages and Supply Chain Vulnerabilities

Parkinson’s and RLS Drug Linked to Risky Impulse Behaviors

UK Drug Shortages Threaten Patient Safety, Pharmacists Warn

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Alberta Plans to Donate Unused Children's Pain Medicine to Ukraine

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Moderna Wins Patent Case Against BioNTech and Pfizer Over mRNA Technology

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

HHS Reconsiders $590 Million Moderna Contract for Bird Flu Vaccine

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

India Halts Aveo Pharmaceuticals Over Illegal Opioid Exports to West Africa

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

German Health Insurance Faces Record Deficits and Risk of Insolvency

USDA Issues Conditional License for Bird Flu Vaccine for Chickens

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Takeda Names Julie Kim as First Female CEO in Company's 240-Year History

Minnesota Secures $35 Monthly Insulin Cap in Landmark Settlement with Novo Nordisk

GSK and Oxford University Partner on £50M Cancer Vaccine Research

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

Purdue Pharma and Sackler Family Agree to $7.4 Billion Opioid Settlement

Sackler Family and Purdue Pharma Agree to $7.4 Billion Settlement Over U.S. Opioid Crisis

Germany Faces First Foot-and-Mouth Disease Outbreak in 35 Years

FDA Approves First Nasal Spray for Treatment-Resistant Depression

Trump Repeals Biden-Era Order on Prescription Drug Pricing

Greek Health Minister Steps In to Distribute Medications After Key Pharmacy Closure

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End

Walgreens Faces DOJ Lawsuit Over Millions of Allegedly Illegal Opioid Prescriptions

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development

DOJ Sues Walgreens Over Millions of Allegedly Illegal Opioid Prescriptions

Medicare Expands Drug Price Negotiations to Include Popular Weight-Loss Medications

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

FTC Report Reveals $7.3 Billion in Drug Markups by Leading PBMs

GLP-1 Drugs Revolutionize Obesity Treatment While Raising Questions About Risks and Costs

Alliance Pharma to Delist After $427 Million Takeover by DBAY Advisors

UK Biobank Launches Largest Proteomics Study to Transform Disease Research

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

Indian Chemical Companies and Executive Charged in U.S. Fentanyl Precursor Trafficking Case

Medicare Implements $2,000 Annual Cap on Prescription Drug Costs

Bottrop Pharmacist Convicted of Diluting Cancer Drugs Released on Parole

Systane Eye Drops Recalled Over Potential Fungal Contamination

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Congress Stalls on PBM Reforms as Trump Vows to Eliminate 'Middlemen'

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

FDA Warns of Adverse Effects and Deaths Linked to Dog Arthritis Drug Librela

Congress Advances Sweeping Health Bill Targeting PBM Practices

New Bipartisan Bill Targets Healthcare Conglomerates' Vertical Integration

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Scientists Engineer 'Superman' Bacteria for Sustainable Chemical Production

Eli Lilly Partners with Ro to Expand Access to Lower-Cost Zepbound Vials

Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies

Australian Women Lose Class Action Against Bayer Over Essure Device

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

PTC Therapeutics and Novartis Sign $3 Billion Deal for Huntington's Disease Drug Development

Mumbai Woman Scammed in 'Digital Arrest' Fraud, Forced to Strip and Pay ₹1.7 Lakh

Global HIV Fight at a Crossroads as Progress Risks Stalling